Conocimiento ancestral sobre el uso de plantas silvestres medicinales en el tratamiento de enfermedades en alpacas / Ancestral knowledge on the use of wild plants for the treatment of diseases in alpacas

In the high Andean areas, the main economic activity is alpaca raising, which is affected by various infectious and parasitic diseases. Rural populations often resort to wild plants that have diverse properties and help control various diseases. The objective was to document the uses of wild plants in the control of alpaca diseases in the high Andean areas of the Puno and Arequipa regions. Fifty alpaca-breeding families were interviewed in five localities. Thirty-two species belonging to 16 families were reported, with the Asteraceae and Fabaceae families having the highest number of species. The most frequently treated pathologies were diarrhea, pneumonia, fever and enteric parasitosis. For diarrhea treatment, the most used plants were M. mollis, S. nutans and T. filifolia, for pneumonia were G. prostrata and G. viravira, for enteric parasitosis were B. tricuneata and L. daucifolia and for the elimination of ectoparasites (lice) was A. compacta. For all diseases, the treatment dose was higher in adults than in neonates and its application is in the rainy season. In acute disease conditions, rural families choice to drugs. Wild plants are a viable and sustainable alternative for the treatment of various diseases in alpacas.

En las zonas altoandinas la principal actividad económica es la crianza de alpacas, las mismas que son afectadas por diversas enfermedades infecciosas y parasitarias. Las poblaciones rurales frecuentemente recurren a las plantas silvestres que tienen diversas propiedades y ayudan al control de diversas enfermedades. El objetivo fue documentar los usos de las plantas silvestres en el control de enfermedades de alpacas en las zonas altoandinas de la región Puno y Arequipa. Se entrevistó a 50 familias criadoras de alpacas en cinco localidades. Se reportaron 32 especies, pertenecientes a 16 familias, siendo la familia Asteraceae y Fabaceae con mayor número de especies. Las patologías que con mayor frecuencia se tratan fueron la diarrea, neumonía, fiebre y parasitosis entérica. Para el tratamiento de diarrea, las plantas más utilizadas fueron M. mollis, S. nutans y T. filifolia, para la nuemonía fueron G. prostrata y G. viravira, para parasitosis entérica fueron B. tricuneata y L. daucifolia y para la eliminación de ectoparásitos (piojos) fue A. compacta. Para todas las enfermedades, las dosis de tratamiento fueron superior en las adultas que en las crías y su aplicación es en la época de lluvias. En condiciones agudas de las enfermedades las familias rurales recurren a los fármacos. Las plantas silvestres, son una alternativa viable y sostenible para el tratamiento de diversas enfermedades en alpacas.

Bovine Colostrum: Its Constituents and Uses.

Colostrum is the milk produced during the first few days after birth and contains high levels of immunoglobulins, antimicrobial peptides, and growth factors. Colostrum is important for supporting the growth, development, and immunologic defence of neonates. Colostrum is naturally packaged in a combination that helps prevent its destruction and maintain bioactivity until it reaches more distal gut regions and enables synergistic responses between protective and reparative agents present within it. Bovine colostrum been used for hundreds of years as a traditional or complementary therapy for a wide variety of ailments and in veterinary practice. Partly due to concerns about the side effects of standard Western medicines, there is interest in the use of natural-based products of which colostrum is a prime example. Numerous preclinical and clinical studies have demonstrated therapeutic benefits of bovine colostrum for a wide range of indications, including maintenance of wellbeing, treatment of medical conditions and for animal husbandry. Articles within this Special Issue of Nutrients cover the effects and use bovine colostrum and in this introductory article, we describe the main constituents, quality control and an overview of the use of bovine colostrum in health and disease.

THE GLOBAL BURDEN OF (HOW WE MANAGE) ANIMAL DISEASE: LEARNING LESSONS FROM SOUTHERN AFRICA.

It is long past the time when we should be recognizing that the potential impacts of animal health interventions focused on livestock may in fact be far from environmentally benign. "First, do no harm" must apply to animal health policy-making as much as these wise words apply to clinical practice. An effort to assess the Global Burden of Animal Diseases, analogous to a long-standing and highly regarded endeavor in the public health realm, has only just been recently announced. This development offers an important opportunity for the formulation of data-driven policy guidance in support of holistic animal health and land-use management decisions that are more likely to be socially, ecologically, and economically sustainable for generations to come.

Delivery and evaluation of participatory education for animal keepers led by veterinarians and para-veterinarians around the Kanha Tiger Reserve, Madhya Pradesh, India.

AIM: We aim to investigate local perceptions of animal health challenges; current animal health knowledge; and methods to provide effective, relevant education to animal keepers in the Kanha Tiger Reserve area. MATERIALS AND METHODS: A farmer education programme was undertaken in the Kanha Tiger Reserve area. Local animal health priorities were investigated through participatory village meetings (n = 38), individual animal keeper questionnaires (n = 100) and a written survey of local paravets (n = 16). Educational interventions were: veterinary surgeon led education meeting (VE); paravet led education meeting (PVE); distribution of printed materials (PM). 230 village meetings were carried out across 181 villages, contacting 3791 animal keepers. 20 villages received printed materials. Information was gathered on perceptions of local animal health challenges and current remedies. Efficacy of knowledge transfer was assessed four to five months later using a purposeful sample of 38 villages. RESULTS: Group meetings identified ticks (35/38), foot and mouth disease (FMD) (31/38) and diarrhoea (30/38) as the greatest animal health challenges. Individual interviews identified haemorrhagic septicaemia (HS) (87/100), blackquarter (BQ) (66/100) and plastic ingestion (31/100). Paravets identified FMD (7/16), BQ (6/16) and HS (6/16), and also indicated that animal husbandry and socio-economic factors were important. Current treatments were primarily home remedies and herbalism, but also included contacting a paravet, use of pharmaceuticals and faith healing. Animal treatment knowledge prior to intervention was not significantly different between groups (P = 0.868). Following intervention animal health knowledge was assessed: PVE performed better than controls (P = 0.001) and PM (P = 0.003); VE performed better than controls (P = 0.009). There was no significant difference between VE and PVE (P = 0.666) nor PM and controls (P = 0.060). CONCLUSIONS AND RECOMMENDATIONS: Open access participatory village meetings are an effective way to provide animal health education. In this region distribution of posters and leaflets did not appear to be an effective way to contact animal keepers. Meetings led by paravets can be as effective as those led by veterinarians and paravets can rapidly and sustainably contact large numbers of animal keepers. Investigation of the local animal health situation is essential to ensure education is relevant and accessible to intended recipients. Interventions must be carefully planned to maximise engagement of all sections of the community, particularly women.

Adjuvants for Animal Vaccines.

Vaccines are essential tools for the prevention and control of infectious diseases in animals. One of the most important steps in vaccine development is the selection of a suitable adjuvant. The focus of this review is the adjuvants used in vaccines for animals. We will discuss current commercial adjuvants and experimental formulations with attention to mineral salts, emulsions, bacterial-derived components, saponins, and several other immunoactive compounds. In addition, we will also examine the mechanisms of action for different adjuvants, examples of adjuvant combinations in one vaccine formulation, and challenges in the research and development of veterinary vaccine adjuvants.

Measuring general animal health status: Development of an animal health barometer.

The development of an animal health barometer, an instrument to measure the general health of the Belgian livestock population on a yearly basis and to monitor its evolution over time, is described. The elaboration of a set of 13 animal health indicators (AHIs) as the basis for the animal health barometer is discussed. These indicators were weighted by experts - including scientists, policy makers and agro-industrial representatives - to determine their relative weight in the barometer. The result of the barometer is expressed as a comparison with a previous year. Based on the results of the 13 AHIs, it is concluded that general animal health in Belgium shows a positive evolution since 2008. The animal health barometer provides a composite view of the status of livestock health in Belgium and is a tool to communicate in an intelligible, comprehensible manner on aspects of animal health to consumers and professional stakeholders in the animal production and food chain. Together with the food safety barometer (Baert et al., 2011. Food Res. Int. 44, 940) and the plant health barometer (Wilmart et al., 2014. Eur. J. Plant Pathol. doi: 10.1007/s10658-014-0547-x), the animal health barometer is one of the three instruments to provide a holistic view on the overall status of the safety of the food chain in Belgium.

From risk analysis to risk governance - Adapting to an ever more complex future.

Risk analysis is now widely accepted amongst veterinary authorities and other stakeholders around the world as a conceptual framework for integrating scientific evidence into animal health decision making. The resulting risk management for most diseases primarily involves linking epidemiological understanding with diagnostics and/or vaccines. Recent disease outbreaks such as Nipah virus, SARS, avian influenza H5N1, bluetongue serotype 8 and Schmallenberg virus have led to realising that we need to explicitly take into account the underlying complex interactions between environmental, epidemiological and social factors which are often also spatially and temporally heterogeneous as well as interconnected across affected regions and beyond. A particular challenge is to obtain adequate understanding of the influence of human behaviour and to translate this into effective mechanisms leading to appropriate behaviour change where necessary. Both, the One Health and the ecohealth approaches reflect the need for such a holistic systems perspective, however the current implementation of risk analysis frameworks for animal health and food safety is still dominated by a natural or biomedical perspective of science as is the implementation of control and prevention policies. This article proposes to integrate the risk analysis approach with a risk governance framework which explicitly adds the socio-economic context to policy development and emphasizes the need for organisational change and stakeholder engagement.

Integrating animal health and foodborne disease surveillance.

The control of foodborne diseases from an animal source has become an important part of public health policy. Since the agents that cause these diseases originate in animals, Veterinary Services, as well as Public Health Services, must be involved in their control. Control programmes should be established either through cooperation between the two Services or by the consolidation of all those involved into a single food control agency. Surveillance is an important part of these control programmes. The following questions must be addressed when planning an effective surveillance programme. What is the relative incidence, morbidity, mortality and economic cost of the foodborne disease in humans? Is the animal population the exclusive or a significant source of the human foodborne infection? What kind of surveillance is needed to identify the disease-causing agent in the animal population? Are we interested in identifying all cases of a disease in order to eradicate it or is our aim to reduce its incidence in the animal population? Do we have the ability to control the disease in the animal population? What disease detection tests are available? What are the sensitivity, specificity and cost of these diagnostic tests? Finally, does the country, region or agency involved have the legal, financial and educational resources to carry out this surveillance and follow it up with appropriate action? After these questions have been resolved,the veterinary and public health sectors must jointly decide if surveillance and control are feasible. If so, they can then begin to develop an appropriate programme.

Antimicrobial use in food and companion animals.

The vast literature on antimicrobial drug use in animals has expanded considerably recently as the antimicrobial resistance (AMR) crisis in human medicine leads to questions about all usage of antimicrobial drugs, including long-term usage in intensively managed food animals for growth promotion and disease prevention. Attention is also increasingly focusing on antimicrobial use and on bacterial resistance in companion animals, which are in intimate contact with the human population. They may share resistant bacteria with their owners, amplify resistant bacteria acquired from their owners, and act as a reservoir for human infection. Considerable effort is being made to describe the basis of AMR in bacterial pathogens of animals. Documentation of many aspects of use of antimicrobials in animals is, however, generally less developed and only a few countries can describe quantities of drugs used in animals to kg levels annually. In recent years, many national veterinary associations have produced 'prudent use guidelines' to try to improve antimicrobial drug use and decrease resistance, but the impact of guidelines is unknown. Within the evolving global movement for 'antimicrobial stewardship', there is considerable scope to improve many aspects of antimicrobial use in animals, including infection control and reduction of use, with a view to reducing resistance and its spread, and to preserving antimicrobial drugs for the future.

The role of nutrients in modulating disease.

The role of nutrition in the management of diseases has often centred on correcting apparent nutrient deficiencies or meeting estimated nutritional requirements of patients. Nutrition has traditionally been considered a supportive measure akin to fluid therapy and rarely it has been considered a primary means of ameliorating diseases. Recently, however, further understanding of the underlying mechanisms of various disease processes and how certain nutrients possess pharmacological properties have fuelled an interest in exploring how nutritional therapies themselves could modify the behaviour of various conditions. Nutrients such as omega-3 fatty acids, antioxidants and certain amino acids such as arginine and glutamine have all been demonstrated to have at least the potential to modulate diseases. Developments in the area of critical care nutrition have been particularly exciting as nutritional therapies utilising a combination of approaches have been shown to positively impact outcome beyond simply proving substrate for synthesis and energy. Application of certain nutrients for the modulation of diseases in veterinary patients is still in early stages, but apparent successes have already been demonstrated, and future studies are warranted to establish optimal approaches. This review describes the rationale of many of these approaches and discusses findings both in human beings and in animals, which may guide future therapy.

The role of plant secondary metabolites in mammalian herbivory: ecological perspectives.

Plant secondary metabolites (PSM) have many ecological functions, but have long been considered as defences against pathogens or herbivores (vertebrate or invertebrate), reducing the likelihood and extent of attack. However, mammalian herbivores ingest many foods containing PSM and use both behavioural methods and physiological strategies to limit their negative effects. Most physiological counter-adaptations are inducible in response to ingested PSM, providing efficient protection against toxic effects. Possible positive effects of PSM include antioxidant and anthelminthic properties and complex formation between protein and condensed tannins that protects dietary protein from degradation by the symbiotic microflora of foregut fermenters, increasing its utilisation by the animal. This protein effect is probably only beneficial to animals under a narrow range of nutrient-rich conditions found mainly in agricultural systems. There are many examples of PSM causing food avoidance or reducing food intake, but there is as yet relatively little evidence for positive selection of them by herbivores. Although the feedback mechanisms relating the post-ingestive consequences of PSM to subsequent foraging behaviour are beginning to be understood, knowledge of the integration of behavioural and physiological strategies for regulating the effects of PSM is relatively poor. The opportunities for learned avoidance of PSM may be restricted in animals with complex diets that cannot associate a particular feedback signal with a given food type. A greater emphasis on the study of subclinical effects of PSM rather than acute effects, on pharmaco-kinetic studies in relation to behavioural studies and on the use of realistic experimental models is advocated.

Portrait of the national veterinary service as a surveillance continuum.

National veterinary services emerged in response to the animal disease challenges of centuries past. Their often singular preoccupation with exogenous disease preclusion yielded, by the early 1900s, to parallel commitments to control a number of serious indigenous, zoonotic infections. Advances in clinical pathology and epidemiology opened the door in many countries to disease, if not agent, eradication initiatives by the latter part of that century. The attending interval witnessed the explosive growth of international trade and the emerging or re-emerging conditions that threaten to accompany it. Animal disease agents, their hosts and the environments within which they interact vary considerably from nation to nation. Depicted as a medieval metaphor, the exogenous cluster around the walls of the castle, awaiting entry upon the next uninspected, unsuspecting fomite or beast. Some of these threats reside comfortably within the structure's bedding and detritus, sapping the vitality of its residents until detected and exterminated. Others emerge from the least expected crevices, growing insidiously or explosively in tandem with changes wrought by humans or nature. In anticipation of, or in response to, these myriad challenges, national veterinary services mount surveillance campaigns. From the national survey that denies the presence of exogenous disease to the post-eradication assessment that confirms its demise, surveillance forms the sensory acumen of the service. From the passive assessments that detect the emerging to the active regimens that plot progress against the indigenous, they form a continuum that defines the very nature of the national veterinary service.

Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control.

Control of soil-transmitted helminth infection and elimination of lymphatic filariasis by periodic chemotherapy increase drug pressure for possible occurrence of resistance against single dose anthelminthics. In veterinary practice, frequent treatment of closed populations has led to a serious problem of anthelminthic drug resistance which is now largely irreversible. Reduced efficacy of single dose drugs against nematodes of humans should be taken as early warnings to tackle the issue in due time. Research and development of sensitive tools for monitoring and early detection of drug resistance is urgently needed to sustain the benefits of helminth control programs gained so far. A concerted action with international partners and the creation of a network of scientists to address this issue is the next pressing public health issue for helminth control.

The use of nutraceuticals in cancer therapy.

The high prevalence of nutraceutical use among human patients with cancer suggests that the use of nutraceuticals in pet animals with cancer is probably common. Dogs with a wide variety of malignant diseases have significant alterations in carbohydrate, protein, and fat metabolism. These metabolic alterations may be ameliorated by using functional foods relatively low in soluble carbohydrate, moderate amounts of protein that includes sources of arginine, and moderate amounts of fat supplemented with omega-3 long-chain polyunsaturated fatty acids. Well-controlled clinical studies in a variety of species with cancer, including rodents, people, and dogs, have documented that increased dietary and serum levels of omega-3 fatty acids are associated with a number of health benefits, including improved disease-free interval, survival time, and quality of life. Other nutraceuticals of interest in patients with cancer include antioxidant vitamins, trace minerals, glutamine, protease inhibitors, garlic, tea polyphenols, vitamin A, and shark cartilage.

An introduction to biosecurity of cattle operations.

Recent world events have heightened awareness for the need to safeguard our livestock industries from disease agents. Biosecurity is the outcome of all activities undertaken to preclude introduction of disease agents into an animal population. The concepts of biosecurity are not new. Activities directed at ensuring biosecurity include controlling exposure and optimizing resistance. Programs for biosecurity must be individually tailored to specific situations to account for varying risks and perceptions of risk by decision makers. It is important for practitioners to take a holistic approach to disease control, considering the epidemiology of the disease in addition to the available vaccines and therapeutics.

Herbal medicine: potential for intoxication and interactions with conventional drugs.

The use of herbal remedies for the prevention and treatment of a variety of illnesses in small animals has increased tremendously in recent years. Whereas most herbal remedies, when used as directed and under the supervision of knowledgeable individuals, are safe, the potential for adverse effects or intoxications certainly exists. Due to inherent toxicity, some herbal remedies should not be used under any circumstance. In addition, because nearly all herbal remedies contain multiple, biologically active constituents, interaction with conventional drugs is a concern. It is incumbent upon clinicians to be aware of those herbs that can cause intoxication, and to be cognizant of potential herb-drug interactions. There are a number of evidence-based resources available to assist clinicians in the safe use of herbal remedies.

The economic implications of animal diseases and disease control at the national level.

The authors examine the economic implications of animal diseases and control programmes at the national level, including the role of government in animal health, the effect of regulations and the use of cost-benefit analysis. Special attention is paid to the role of economic analysis in government decision-making processes. Economics provides a framework for gathering information and for the presentation of that information in a methodical manner, thereby providing a method for the decision maker to examine policy alternatives. In addition, assumptions underlying the analysis must be clearly laid out and explained by the person undertaking the analysis. Economic reasons for government intervention in animal health programmes include externalities, natural monopolies, public goods, coordination failure, information failure and distribution issues. An integrated holistic approach that includes national and international policy objectives is outlined in the paper. In the approach outlined, government coordinates the activities of stakeholders in animal health, including producers, consumers and researchers.